These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29572828)

  • 1. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
    Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
    J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor budding in biliary tract cancer.
    Regmi P; Paudyal A; Paudyal P; Hu HJ; Liu F; Ma WJ; Jin YW; Li FY
    Eur J Surg Oncol; 2022 Jan; 48(1):160-168. PubMed ID: 34412954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
    Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
    Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
    Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
    J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
    Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
    J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
    Buettner S; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Weiss M; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Koerkamp BG; Maithel SK; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1813-1820. PubMed ID: 28913712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.
    Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M
    Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of multicentric adenocarcinomas of the biliary tract.
    Kobayashi S; Konishi M; Kato Y; Gotohda N; Takahashi S; Kinoshita T; Kinoshita T; Kojima M
    Jpn J Clin Oncol; 2011 Sep; 41(9):1079-85. PubMed ID: 21875937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
    Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
    Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
    Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic risk factors of early esophageal adenocarcinomas.
    Lorenz D; Origer J; Pauthner M; Graupe F; Fisseler-Eckhoff A; Stolte M; Pech O; Ell C
    Ann Surg; 2014 Mar; 259(3):469-76. PubMed ID: 24096754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
    Takayama H; Kobayashi S; Gotoh K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Wada H; Takahashi H; Tanemura M; Doki Y; Eguchi H
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10935-10950. PubMed ID: 37330435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract.
    Uhl B; Dietrich D; Branchi V; Semaan A; Schaefer P; Gevensleben H; Rostamzadeh B; Lingohr P; Schäfer N; Kalff JC; Kristiansen G; Matthaei H
    PLoS One; 2016; 11(10):e0165769. PubMed ID: 27798672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.